Difference between revisions of "Team:KU Leuven"

Line 28: Line 28:
  
 
body {
 
body {
 +
  background: #262525;
 
  font-family: 'Open Sans', Helvetica, Arial, sans-serif;
 
  font-family: 'Open Sans', Helvetica, Arial, sans-serif;
 
}
 
}
Line 511: Line 512:
 
}
 
}
 
.animated_svg1 > * {
 
.animated_svg1 > * {
position: center;
+
position: absolute;
 
}
 
}
 
.animated_svg2 {
 
.animated_svg2 {
Line 655: Line 656:
 
  </div>
 
  </div>
 
</div>
 
</div>
  <!-- cont inner end -->
+
<div style="text-align:center">
</div>
+
<div style="text-align:center">
+
 
<div class="animated_svg1">
 
<div class="animated_svg1">
 
<svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
 
<svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
Line 736: Line 735:
 
                        </a>
 
                        </a>
 
                    </svg>
 
                    </svg>
 +
  <!-- cont inner end -->
 +
</div>
 +
 
                </div>
 
                </div>
 
            </div>
 
            </div>

Revision as of 02:49, 14 September 2017

KU Leuven

HEKcite
1
1

Project

Inspired by the heart

We drew our inspiration from the versatility and robustness of the heart. It beats continuously over the years, rapidly adapting its pace when necessary.
2
2

Research

Creation of the Rhythm

Given our knowledge about heart currents, we hypothesized it would be possible to recreate a steady rhythm in a non-excitable cell using only three ion channels.
3
3

Application

Biosensing

Finally, we aim to influence the pace by varying concentrations of biological effectors. Our main focus is establishing a new form of therapeutic drug monitoring.
4
4

Contact

Contact
5
5